編號
R3-003
徵稿主題
Clinical Trial / Chemotherapy / Targeted Therapy / Immunotherapy / Cell Therapy
題目
KRAS 突變於晚期膽道癌之臨床意義：多中心真實世界資料分析
作者群
蘇勇曄1,2,
林欣辰3,
石宇軒3,
杜政勳4,
Hong Jae Chon5,
Choong-Kun Lee6,
Masato Ozaka7,
Takeshi Okamoto7,
Masayuki Ueno8,
陳立宗1,2,4,
李安富2
服務單位
1 National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan
2 Deparment of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan
3 Department of Oncology, Taichung Veterans General Hospital, Taichung, Taiwan.
4 Department of Internal Medicine, Kaohsiung Medical University Hospital, and Center for Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan
5 CHA Bundang Medical Center, Seongnam, South Korea.
6 Yonsei Cancer Center, Seoul, South Korea.
7 The Cancer Institute Hospital of JFCR, Tokyo, Japan
8 Kurashiki Central Hospital, Kurashiki, Japan
